Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis

ABSTRACT The current tuberculosis (TB) vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), provides insufficient protection against pulmonary TB. Previously, we generated a listeriolysin-expressing recombinant BCG strain, which to date has successfully completed phase I and phase IIa clinic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martin Gengenbacher, Natalie Nieuwenhuizen, Alexis Vogelzang, Haipeng Liu, Peggy Kaiser, Stefanie Schuerer, Doris Lazar, Ina Wagner, Hans-Joachim Mollenkopf, Stefan H. E. Kaufmann
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://doaj.org/article/a3795285567a431ba72958df4832df9e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a3795285567a431ba72958df4832df9e
record_format dspace
spelling oai:doaj.org-article:a3795285567a431ba72958df4832df9e2021-11-15T15:50:17ZDeletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis10.1128/mBio.00679-162150-7511https://doaj.org/article/a3795285567a431ba72958df4832df9e2016-07-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00679-16https://doaj.org/toc/2150-7511ABSTRACT The current tuberculosis (TB) vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), provides insufficient protection against pulmonary TB. Previously, we generated a listeriolysin-expressing recombinant BCG strain, which to date has successfully completed phase I and phase IIa clinical trials. In an attempt to further improve efficacy, we deleted the antiapoptotic virulence gene nuoG, encoding NADH dehydrogenase 1 subunit G, from BCG ΔureC::hly. In vitro, deletion of nuoG unexpectedly led to strongly increased recruitment of the autophagosome marker LC3 to the engulfed vaccine, suggesting that nuoG also affects xenophagic pathways. In mice, BCG ΔureC::hly ΔnuoG vaccination was safer than BCG and improved protection over that of parental BCG ΔureC::hly, significantly reducing TB load in murine lungs, ameliorating pulmonary pathology, and enhancing immune responses. Transcriptome analysis of draining lymph nodes after vaccination with either BCG ΔureC::hly or BCG ΔureC::hly ΔnuoG demonstrated earlier and stronger induction of immune responses than that with BCG SSI and suggested upregulation of inflammasome activation and interferon-induced GTPases. In summary, BCG ΔureC::hly ΔnuoG is a promising next-generation TB vaccine candidate with excellent efficacy and safety. IMPORTANCE Autophagy and apoptosis are fundamental processes allowing cells to degrade their components or kill themselves, respectively. The immune system has adopted these mechanisms to eliminate intracellular pathogens. Residing in host cells, the causative agent of tuberculosis, Mycobacterium tuberculosis, has evolved strategies to set cellular programs of autophagy and apoptosis “on hold.” The mycobacterial gene nuoG was found to prevent host cell apoptosis. We have deleted nuoG in the live vaccine candidate BCG ΔureC::hly, which is in phase II clinical development, to leave cellular apoptosis “on go” upon immunization. In preclinical models, this strategy boosted immunity and improved protection from M. tuberculosis infection. Unexpectedly, we obtained compelling evidence that mycobacterial nuoG facilitates inhibition of autophagic pathways, suggesting a new role for this gene in the host-pathogen interplay in tuberculosis.Martin GengenbacherNatalie NieuwenhuizenAlexis VogelzangHaipeng LiuPeggy KaiserStefanie SchuererDoris LazarIna WagnerHans-Joachim MollenkopfStefan H. E. KaufmannAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 3 (2016)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Martin Gengenbacher
Natalie Nieuwenhuizen
Alexis Vogelzang
Haipeng Liu
Peggy Kaiser
Stefanie Schuerer
Doris Lazar
Ina Wagner
Hans-Joachim Mollenkopf
Stefan H. E. Kaufmann
Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
description ABSTRACT The current tuberculosis (TB) vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), provides insufficient protection against pulmonary TB. Previously, we generated a listeriolysin-expressing recombinant BCG strain, which to date has successfully completed phase I and phase IIa clinical trials. In an attempt to further improve efficacy, we deleted the antiapoptotic virulence gene nuoG, encoding NADH dehydrogenase 1 subunit G, from BCG ΔureC::hly. In vitro, deletion of nuoG unexpectedly led to strongly increased recruitment of the autophagosome marker LC3 to the engulfed vaccine, suggesting that nuoG also affects xenophagic pathways. In mice, BCG ΔureC::hly ΔnuoG vaccination was safer than BCG and improved protection over that of parental BCG ΔureC::hly, significantly reducing TB load in murine lungs, ameliorating pulmonary pathology, and enhancing immune responses. Transcriptome analysis of draining lymph nodes after vaccination with either BCG ΔureC::hly or BCG ΔureC::hly ΔnuoG demonstrated earlier and stronger induction of immune responses than that with BCG SSI and suggested upregulation of inflammasome activation and interferon-induced GTPases. In summary, BCG ΔureC::hly ΔnuoG is a promising next-generation TB vaccine candidate with excellent efficacy and safety. IMPORTANCE Autophagy and apoptosis are fundamental processes allowing cells to degrade their components or kill themselves, respectively. The immune system has adopted these mechanisms to eliminate intracellular pathogens. Residing in host cells, the causative agent of tuberculosis, Mycobacterium tuberculosis, has evolved strategies to set cellular programs of autophagy and apoptosis “on hold.” The mycobacterial gene nuoG was found to prevent host cell apoptosis. We have deleted nuoG in the live vaccine candidate BCG ΔureC::hly, which is in phase II clinical development, to leave cellular apoptosis “on go” upon immunization. In preclinical models, this strategy boosted immunity and improved protection from M. tuberculosis infection. Unexpectedly, we obtained compelling evidence that mycobacterial nuoG facilitates inhibition of autophagic pathways, suggesting a new role for this gene in the host-pathogen interplay in tuberculosis.
format article
author Martin Gengenbacher
Natalie Nieuwenhuizen
Alexis Vogelzang
Haipeng Liu
Peggy Kaiser
Stefanie Schuerer
Doris Lazar
Ina Wagner
Hans-Joachim Mollenkopf
Stefan H. E. Kaufmann
author_facet Martin Gengenbacher
Natalie Nieuwenhuizen
Alexis Vogelzang
Haipeng Liu
Peggy Kaiser
Stefanie Schuerer
Doris Lazar
Ina Wagner
Hans-Joachim Mollenkopf
Stefan H. E. Kaufmann
author_sort Martin Gengenbacher
title Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
title_short Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
title_full Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
title_fullStr Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
title_full_unstemmed Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
title_sort deletion of <italic toggle="yes">nuog</italic> from the vaccine candidate <named-content content-type="genus-species">mycobacterium bovis</named-content> bcg δ<italic toggle="yes">urec</italic>::<italic toggle="yes">hly</italic> improves protection against tuberculosis
publisher American Society for Microbiology
publishDate 2016
url https://doaj.org/article/a3795285567a431ba72958df4832df9e
work_keys_str_mv AT martingengenbacher deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT natalienieuwenhuizen deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT alexisvogelzang deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT haipengliu deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT peggykaiser deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT stefanieschuerer deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT dorislazar deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT inawagner deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT hansjoachimmollenkopf deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
AT stefanhekaufmann deletionofitalictoggleyesnuogitalicfromthevaccinecandidatenamedcontentcontenttypegenusspeciesmycobacteriumbovisnamedcontentbcgditalictoggleyesurecitalicitalictoggleyeshlyitalicimprovesprotectionagainsttuberculosis
_version_ 1718427417605832704